Keywords: Roche, Avastin, Breast cancer, UK, NICE

NICE turns down Roche breast cancer drug Avastin, citing too many uncertainties

Article | 18 April 2012

Print This

UK drug watchdog the National Institute for Health and Clinical Excellence (NICE), said this morning that it has opened ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in